2005 Team In Training Journey - - - San Diego, Here I Come!!

Raising Money

Home
What's coming up
My Story
Some Links
Contact me
Pictures
Raising Money
My Training
Training Schedule
Journal
You can help!

GOAL: $3,900
Total Raised to date:  $
 

pigbank.gif

Thank you so much for your generousity and continued support!

Click here to make a donation! Every dollar helps!

The Leukemia & Lymphoma Society dedicates 75 percent of every dollar spent to advance its mission to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and to improve the quality of life of patients and their families. The Society meets the Better Business Standards for ethical conduct and charitable accountability.

The Society's Team In Training® (TNT) is first and foremost a fundraising program. Our primary goal is to raise funds for blood cancer research, public education and patient aid programs. In light of this objective, we take your commitment to raising the fundraising minimum seriously. We want you to be successful in raising at least the minimum and have structured the program to provide as much support as possible.

A fundraising goal is established for each TNT participant. The fundraising commitment for each participant is established based on the location of the event they will attend. The Society utilizes travel discounts and group rates to keep costs low. Once participants meet their fundraising goal, they are sent to a national or international endurance event.

The Society has five priority programs to help reach its goal of finding cures to eliminate leukemia, lymphoma and myeloma:

  • Our research initiatives support projects throughout the world.
  • The Patient Financial Aid Program provides free financial and emotional support to those affected by blood cancer.
  • Various public education programs provide free materials to the public.
  • The Community Service Program works with community services and agencies to meet patient needs.
  • The Professional Education Program provides continuing education opportunities for healthcare professionals with regard to the latest advances in leukemia, lymphoma and myeloma treatment.